Extendicare (TSE:EXE – Free Report) had its price target lifted by TD Securities from C$10.50 to C$13.00 in a report published on Monday,BayStreet.CA reports. TD Securities currently has a hold rating on the stock.
Several other equities analysts also recently commented on EXE. BMO Capital Markets raised their target price on Extendicare from C$11.00 to C$13.50 in a research report on Monday. Cormark upgraded shares of Extendicare to a “moderate buy” rating in a research note on Wednesday, February 19th. Finally, Royal Bank of Canada increased their target price on shares of Extendicare from C$9.50 to C$11.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 28th. Three research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of C$11.50.
Check Out Our Latest Stock Report on Extendicare
Extendicare Stock Performance
Extendicare Dividend Announcement
The firm also recently disclosed a monthly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 17th will be paid a $0.04 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 3.81%. The ex-dividend date of this dividend is Friday, February 28th. Extendicare’s dividend payout ratio is currently 61.20%.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Further Reading
- Five stocks we like better than Extendicare
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- How to Plot Fibonacci Price Inflection Levels
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Stock Average Calculator
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.